OMC provides Aclasta infusions for osteoporosis treatment at their orthopedic multispecialty center located within The Medical City hospital. Their target patient is empowered women aged 50 and older. OMC differentiates itself by offering convenience through its location and services. It markets directly to nearby communities and relies on referrals from TMC consultants. While OMC charges a premium price for treatment, it aims to attract customers through service quality and differentiation within the osteoporosis treatment market.